Authors
Joanna Rhodes, MD, MSCE, is the director of the lymphoma program at the Rutgers Cancer Institute and assistant head of lymphoma at Robert Wood Johnson.
Christopher Shade, PhD, founder and CEO, Quicksilver Scientific.
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access
5
